CDRD & Aequus are collaborating & sharing respective expertise that could lead to new cannabinoid therapeutics and a pathway to clinical trials, particularly in neurological movement disorders.
Gordon McCauley, President and CEO of CDRD, and an expert panel explored the current challenges to health innovation and offers solutions to ensure a vibrant life sciences sector that pays economic and health dividends down the road.
Join us at the 2nd Personalized Medicine Summit 2017, June 11-13 2017 at the University of British Columbia (UBC).
Meet Amber, Katrina from Pigeon Lake, AB, Lucas from Rorketon, MB and Destiny from Gift Lake, AB who have joined the CDRD team in our Target Validation and Analytical Chemistry divisions from May 15-19.
NeuroCDRD, a new drug development platform jointly led by CDRD, the Montreal Neurological Institute and Hospital at McGill University (MNI), & Merck aims to accelerate the development of new treatments for ALS and Parkinson’s disease.
CDRD is proud to a founding partner of the Regenerative Medicine Alliance of Canada along with other founding members: CCRM; CellCan; Medicine by Design; Ontario Institute for Regenerative Medicine; ThéCell; Canadian Stem Cell Foundation, and Stem Cell Network.
CDRD is a partner in one of 16 new collaborative research projects announced by BioCanRx. These projects are aimed at finding improved treatment options and outcomes for cancer patients and developing clinical Chimeric Antigen Receptor modified T cell (CAR-T) manufacturing capabilities in Canada.
Health sciences researchers, entrepreneurs, and companies alike have the opportunity to collaborate with CDRD and thereby access its full suite of expertise, infrastructure, and broad partnerships and networks.
CDRD BY THE NUMBERS:
Headquartered in Vancouver, British Columbia, The Centre for Drug Research and Development (CDRD) is Canada’s national drug development and commercialization engine.
We work in partnership with academia, industry, government and foundations, to provide the specialized expertise and infrastructure to identify and de-risk promising discoveries generated by health-related research, and transform them into commercially viable investment opportunities for the private sector – and ultimately into innovative new therapies for patients.
In doing so, CDRD is actively growing our national health sciences industry into a wholly-optimized generator of economic prosperity for the country.
Since 2008, Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).